The HCPLive asthma page is a comprehensive resource for clinical news and insights on asthmatic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for allergic and severe asthma, and more.
November 14th 2024
A new analysis highlights the seasonal patterns of airborne fungal spores that can be found in the central region of England, with a calendar developed to this same end.
Omalizumab Highly Effective for Treatment of Chronic Spontaneous Urticaria
A study in Drug Design, Development, and Therapy provides further evidence that omalizumab is safe and effective for treatment of chronic spontaneous urticaria (CSU). Omalizumab is currently used to treat adult and pediatric patients with asthma and is FDA-approved for use in patients with CSU refractory to antihistamines. These results further outline the effectiveness of the drug in treating CSU and suggest a bump for omalizumab in the typical treatment protocol for CSU.
Asthma Ally App Can Help Patients Achieve Better Asthma Control
The Asthma Ally app can track patients' symptoms and alert their physicians when those symptoms are not under control, according to findings of a study published in the Annals of Allergy, Asthma and Immunology.
Children with Asthma and Eczema More Likely to Be Bullied at School
As summer comes to a close and many have already sent their children off to a new year of school, a study in PLOS One suggests that children who have asthma or eczema may face significant challenges fitting in with their peers.
Asthma, COPD Sometimes Overlap, Specialists Say
Specialists agree that a condition unofficially known as asthma-COPD overlap syndrome (ACOS) exists, according to a survey completed by Marc Miravitlles, MD, and colleagues. The participants were 26 specialists in either asthma or chronic obstructive pulmonary disease (COPD practicing in Spain. They first completed a structured questionnaire, and then attended an in-person work meeting that followed the Metaplan technique.
What Can Early-Life Vitamin D Levels Tell Us About Allergy-Related Outcomes?
Vitamin D insufficiency can be like the slippery suspect in a network procedural: It's probably up to no good on any number of counts, but pinning the crime on it with airtight evidence can still prove elusive.
Long-Term Clinical Outcomes with Sublingual Immunotherapy
April 27th 2015SLIT-tablets have a safety profile suitable for home treatment, as long as the first tablet intake is done under medical supervision. Long-term outcomes seem to differ between grass pollen SLIT-tablet products, and further studies are required.
Breathmobile Provides Needed Treatment to Students Nationwide
As one of the largest school districts in the country, the Los Angeles Unified School District serves more than 600,000 students on a daily basis. With so many children come a wide variety of health issues and individual health insurance complications that also must be addressed.